Walnut extracts for nutraceutical applications
OwnerThomas Eidenbergerinventor
Life of this patent
Estimating the term…
Abstract
The invention describes to walnut oil extracts that have increased amounts of enriched in phospholipids, especially phosphatidylethanolamine (PE), phosphatidylcholine (PC), and phosphatidylinositol (PI) relative to walnut oil found in naturally occurring walnuts. It has been found that there are synergistic therapeutic effects when PE/PC and/or PI are combined.
Claims32
A walnut extract composition comprising phosphatidylethanolamine (PE) and phosphatidylcholine (PC), wherein the ratio of PE to PC is greater than about 0.43 by weight.
A walnut extract composition comprising phosphatidylinositol (PI) and phosphatidylcholine (PC), wherein the ratio of PI to PC is greater than about 0.88 by weight.
A walnut extract composition comprising phosphatidylinositol (PI) and phosphatidylethanolamine (PE), wherein the ratio of PI to PE is greater than about 0.4 by weight.
A lipid composition derived from walnut extract comprising at least about 10% by weight of phospholipids.
A composition comprising phosphatidylethanolamine (PE), phosphatidylcholine (PC) and phosphatidylinositol (PI).
Dependencies are inferred from the claim text.